Related Experiment Video

Updated: May 17, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia

Vanessa Schneider1, Stephanie Egenrieder, Marlies Götz

  • 1Department of Internal Medicine III, University of Ulm, Ulm, Germany.

Leukemia & Lymphoma
|October 30, 2012
PubMed

Insights

This study shows that specific T cell responses can be generated against Aurora kinase epitopes in acute myeloid leukemia (AML) patients. These findings suggest a potential role for Aurora kinase-targeted immunotherapy in AML treatment.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Aurora kinases are crucial for mitosis and cell cycle regulation.
  • Overexpressed in various cancers, including acute myeloid leukemia (AML).
  • Aurora kinase inhibitors show potential in sensitizing cancer cells to therapies.

Purpose of the Study:

  • To investigate if Aurora kinase A and B epitopes can elicit cellular immune responses in AML patients.
  • To explore the potential of these epitopes as targets for specific immunotherapy.
  • To compare immune responses in AML patients versus healthy volunteers.

Main Methods:

  • Enzyme-linked immunosorbent spot (ELISpot) assays were used.
  • Eight AML patients and nine healthy volunteers (HVs) were analyzed.
  • Specific CD8+ T cell responses against Aurora kinase epitopes were measured.

Main Results:

  • Specific CD8+ T cell responses were detected against multiple Aurora kinase epitopes (Aura A1, A2, B1-B5).
  • Epitopes from Aurora kinase B induced immune responses more frequently than those from Aurora kinase A.
  • Aura B3, B4, and B5 showed the most frequent cytotoxic T-lymphocyte (CTL) responses in AML patients.

Conclusions:

  • Aurora kinase epitopes can elicit cellular immune responses in AML patients.
  • Aurora kinase B-derived epitopes are promising targets for immunotherapy.
  • Combining Aurora kinase inhibitors with immunotherapy may enhance blast and minimal residual disease elimination in AML.

More Related Videos

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...